These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2477188)

  • 21. Idiotypic interactions between normal human polyspecific IgG and natural IgM antibodies.
    Rossi F; Guilbert B; Tonnelle C; Ternynck T; Fumoux F; Avrameas S; Kazatchkine MD
    Eur J Immunol; 1990 Sep; 20(9):2089-94. PubMed ID: 2209705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Idiotypic modulation of autoimmunity by therapeutic human immunoglobulin preparations (IVIg).
    Kaveri SV; Dietrich G; Jobin D; Rossi F; Sultan Y; Lockwood CM; Kazatchkine MD
    Adv Nephrol Necker Hosp; 1992; 21():329-46. PubMed ID: 1566650
    [No Abstract]   [Full Text] [Related]  

  • 23. Idiotypes in autoimmune diseases.
    Colvin RB; Olson KA
    Concepts Immunopathol; 1985; 1():133-72. PubMed ID: 3916401
    [No Abstract]   [Full Text] [Related]  

  • 24. Cross-reactive idiotypes on high affinity IgG class human monoclonal thyroglobulin autoantibodies.
    Delves PJ; McLachlan SM; Drewe E; Fukuma N; Petersen VB; Smith BR
    J Autoimmun; 1993 Feb; 6(1):77-91. PubMed ID: 8457287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of autoimmunity by intravenous immune globulin through interaction with the function of the immune/idiotypic network.
    Dietrich G; Kaveri SV; Kazatchkine MD
    Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 2):S73-81. PubMed ID: 1728990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human monoclonal multiple-organ-reactive autoantibodies distinguished by mouse monoclonal anti-idiotypic antibodies: expression of idiotopes in humans with and without autoimmune diseases.
    Uchigata Y; Prabhakar BS; Salata KF; Ginsberg-Fellner F; Notkins AL
    J Immunol; 1987 Jun; 138(12):4218-21. PubMed ID: 3495582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-idiotypes to factor VIII antibodies and their possible role in the pathogenesis and treatment of factor VIII inhibitors.
    Moffat EH; Furlong RA; Dannatt AH; Bloom AL; Peake IR
    Br J Haematol; 1989 Jan; 71(1):85-90. PubMed ID: 2492821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factor VIII Inhibitors. Natural autoantibodies and anti-idiotypes.
    Gilles JG; Vanzieleghem B; Saint-Remy JM
    Semin Thromb Hemost; 2000; 26(2):151-5. PubMed ID: 10919407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Normal immunoglobulin G (IgG) for therapeutic use (intravenous Ig) contain antiidiotypic specificities against an immunodominant, disease-associated, cross-reactive idiotype of human anti-thyroglobulin autoantibodies.
    Dietrich G; Kazatchkine MD
    J Clin Invest; 1990 Mar; 85(3):620-5. PubMed ID: 2312717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Idiotypy and autoimmunity.
    Klinman DM; Steinberg AD
    Arthritis Rheum; 1986 Jun; 29(6):697-705. PubMed ID: 2424459
    [No Abstract]   [Full Text] [Related]  

  • 31. Normal polyspecific immunoglobulin G (IVIg) in the treatment of autoimmune diseases.
    Hurez V; Kaveri SV; Kazatchkine MD
    J Autoimmun; 1993 Dec; 6(6):675-81. PubMed ID: 8155249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Idiotypic heterogeneity of VKIII autoantibodies to red blood cell antigens.
    Jefferies LC; Silverman GJ; Carchidi CM; Silberstein LE
    Clin Immunol Immunopathol; 1992 Nov; 65(2):119-28. PubMed ID: 1395128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Idiotype, anti-idiotype network of autoantibodies: pathogenetic considerations and clinical application.
    Tzioufas AG; Routsias JG
    Autoimmun Rev; 2010 Jul; 9(9):631-3. PubMed ID: 20478412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Anti-idiotype suppression of autoimmunity by therapeutic intravenous immunoglobulins].
    Rossi F; Dietrich G; Kazatchkine M
    Ann Med Interne (Paris); 1988; 139(5):359-68. PubMed ID: 3144223
    [No Abstract]   [Full Text] [Related]  

  • 35. Pooled normal human polyspecific IgM contains neutralizing anti-idiotypes to IgG autoantibodies of autoimmune patients and protects from experimental autoimmune disease.
    Hurez V; Kazatchkine MD; Vassilev T; Ramanathan S; Pashov A; Basuyaux B; de Kozak Y; Bellon B; Kaveri SV
    Blood; 1997 Nov; 90(10):4004-13. PubMed ID: 9354669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recovery from anti-VIII:C (antihemophilic factor) autoimmune disease is dependent on generation of antiidiotypes against anti-VIII:C autoantibodies.
    Sultan Y; Rossi F; Kazatchkine MD
    Proc Natl Acad Sci U S A; 1987 Feb; 84(3):828-31. PubMed ID: 3101065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous immunoglobulin in the treatment of spontaneously acquired factor VIII:C inhibitors.
    Sultan Y; Kazatchkine MD; Nydegger U; Rossi F; Dietrich G; Algiman M
    Am J Med; 1991 Nov; 91(5A):35S-39S. PubMed ID: 1746595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selectivity of recognition of variable (V) regions of autoantibodies by intravenous immunoglobulin (IVIg).
    Ronda N; Haury M; Nobrega A; Coutinho A; Kazatchkine MD
    Clin Immunol Immunopathol; 1994 Feb; 70(2):124-8. PubMed ID: 8299227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Idiotypes and anti-idiotypes in experimental autoimmune myasthenia gravis.
    Souroujon MC; Fuchs S
    Ann N Y Acad Sci; 1986; 475():81-93. PubMed ID: 3491567
    [No Abstract]   [Full Text] [Related]  

  • 40. The efficacy of specific IVIG anti-idiotypic antibodies in antiphospholipid syndrome (APS): trophoblast invasiveness and APS animal model.
    Blank M; Anafi L; Zandman-Goddard G; Krause I; Goldman S; Shalev E; Cervera R; Font J; Fridkin M; Thiesen HJ; Shoenfeld Y
    Int Immunol; 2007 Jul; 19(7):857-65. PubMed ID: 17576752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.